An inhalation drug delivery device is a device used to deliver drugs into the patient's respiratory tract in the form of aerosol or atomized liquid for the purpose of treating respiratory diseases.
The global Inhalation Drug Delivery Device market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淚nhalation Drug Delivery Device Industry Forecast鈥� looks at past sales and reviews total world Inhalation Drug Delivery Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhalation Drug Delivery Device sales for 2024 through 2030. With Inhalation Drug Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation Drug Delivery Device industry.
This Insight Report provides a comprehensive analysis of the global Inhalation Drug Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalation Drug Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Inhalation Drug Delivery Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation Drug Delivery Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation Drug Delivery Device.
United States market for Inhalation Drug Delivery Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Inhalation Drug Delivery Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Inhalation Drug Delivery Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Inhalation Drug Delivery Device players cover Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation Drug Delivery Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pressurized Metered Dose Inhalation System
Dry Powder Inhalation System
Soft Mist Inhalation System
Others
Segmentation by Application:
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent
Key Questions Addressed in this Report
What is the 10-year outlook for the global Inhalation Drug Delivery Device market?
What factors are driving Inhalation Drug Delivery Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalation Drug Delivery Device market opportunities vary by end market size?
How does Inhalation Drug Delivery Device break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inhalation Drug Delivery Device Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhalation Drug Delivery Device by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhalation Drug Delivery Device by Country/Region, 2019, 2023 & 2030
2.2 Inhalation Drug Delivery Device Segment by Type
2.2.1 Pressurized Metered Dose Inhalation System
2.2.2 Dry Powder Inhalation System
2.2.3 Soft Mist Inhalation System
2.2.4 Others
2.3 Inhalation Drug Delivery Device Sales by Type
2.3.1 Global Inhalation Drug Delivery Device Sales Market Share by Type (2019-2024)
2.3.2 Global Inhalation Drug Delivery Device Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhalation Drug Delivery Device Sale Price by Type (2019-2024)
2.4 Inhalation Drug Delivery Device Segment by Application
2.4.1 Bronchial Asthma
2.4.2 Chronic Obstructive Pulmonary Disease
2.4.3 Others
2.5 Inhalation Drug Delivery Device Sales by Application
2.5.1 Global Inhalation Drug Delivery Device Sale Market Share by Application (2019-2024)
2.5.2 Global Inhalation Drug Delivery Device Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhalation Drug Delivery Device Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Inhalation Drug Delivery Device Breakdown Data by Company
3.1.1 Global Inhalation Drug Delivery Device Annual Sales by Company (2019-2024)
3.1.2 Global Inhalation Drug Delivery Device Sales Market Share by Company (2019-2024)
3.2 Global Inhalation Drug Delivery Device Annual Revenue by Company (2019-2024)
3.2.1 Global Inhalation Drug Delivery Device Revenue by Company (2019-2024)
3.2.2 Global Inhalation Drug Delivery Device Revenue Market Share by Company (2019-2024)
3.3 Global Inhalation Drug Delivery Device Sale Price by Company
3.4 Key Manufacturers Inhalation Drug Delivery Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalation Drug Delivery Device Product Location Distribution
3.4.2 Players Inhalation Drug Delivery Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Inhalation Drug Delivery Device by Geographic Region
4.1 World Historic Inhalation Drug Delivery Device Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhalation Drug Delivery Device Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhalation Drug Delivery Device Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhalation Drug Delivery Device Market Size by Country/Region (2019-2024)
4.2.1 Global Inhalation Drug Delivery Device Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhalation Drug Delivery Device Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalation Drug Delivery Device Sales Growth
4.4 APAC Inhalation Drug Delivery Device Sales Growth
4.5 Europe Inhalation Drug Delivery Device Sales Growth
4.6 Middle East & Africa Inhalation Drug Delivery Device Sales Growth
5 Americas
5.1 Americas Inhalation Drug Delivery Device Sales by Country
5.1.1 Americas Inhalation Drug Delivery Device Sales by Country (2019-2024)
5.1.2 Americas Inhalation Drug Delivery Device Revenue by Country (2019-2024)
5.2 Americas Inhalation Drug Delivery Device Sales by Type (2019-2024)
5.3 Americas Inhalation Drug Delivery Device Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation Drug Delivery Device Sales by Region
6.1.1 APAC Inhalation Drug Delivery Device Sales by Region (2019-2024)
6.1.2 APAC Inhalation Drug Delivery Device Revenue by Region (2019-2024)
6.2 APAC Inhalation Drug Delivery Device Sales by Type (2019-2024)
6.3 APAC Inhalation Drug Delivery Device Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Inhalation Drug Delivery Device by Country
7.1.1 Europe Inhalation Drug Delivery Device Sales by Country (2019-2024)
7.1.2 Europe Inhalation Drug Delivery Device Revenue by Country (2019-2024)
7.2 Europe Inhalation Drug Delivery Device Sales by Type (2019-2024)
7.3 Europe Inhalation Drug Delivery Device Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inhalation Drug Delivery Device by Country
8.1.1 Middle East & Africa Inhalation Drug Delivery Device Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhalation Drug Delivery Device Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhalation Drug Delivery Device Sales by Type (2019-2024)
8.3 Middle East & Africa Inhalation Drug Delivery Device Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalation Drug Delivery Device
10.3 Manufacturing Process Analysis of Inhalation Drug Delivery Device
10.4 Industry Chain Structure of Inhalation Drug Delivery Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalation Drug Delivery Device Distributors
11.3 Inhalation Drug Delivery Device Customer
12 World Forecast Review for Inhalation Drug Delivery Device by Geographic Region
12.1 Global Inhalation Drug Delivery Device Market Size Forecast by Region
12.1.1 Global Inhalation Drug Delivery Device Forecast by Region (2025-2030)
12.1.2 Global Inhalation Drug Delivery Device Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Inhalation Drug Delivery Device Forecast by Type (2025-2030)
12.7 Global Inhalation Drug Delivery Device Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Aptar Pharma
13.1.1 Aptar Pharma Company Information
13.1.2 Aptar Pharma Inhalation Drug Delivery Device Product Portfolios and Specifications
13.1.3 Aptar Pharma Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Aptar Pharma Main Business Overview
13.1.5 Aptar Pharma Latest Developments
13.2 Nemera
13.2.1 Nemera Company Information
13.2.2 Nemera Inhalation Drug Delivery Device Product Portfolios and Specifications
13.2.3 Nemera Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nemera Main Business Overview
13.2.5 Nemera Latest Developments
13.3 Porex
13.3.1 Porex Company Information
13.3.2 Porex Inhalation Drug Delivery Device Product Portfolios and Specifications
13.3.3 Porex Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Porex Main Business Overview
13.3.5 Porex Latest Developments
13.4 Chiesi Farmaceutici
13.4.1 Chiesi Farmaceutici Company Information
13.4.2 Chiesi Farmaceutici Inhalation Drug Delivery Device Product Portfolios and Specifications
13.4.3 Chiesi Farmaceutici Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Chiesi Farmaceutici Main Business Overview
13.4.5 Chiesi Farmaceutici Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Inhalation Drug Delivery Device Product Portfolios and Specifications
13.5.3 AstraZeneca Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 H&T Presspart
13.6.1 H&T Presspart Company Information
13.6.2 H&T Presspart Inhalation Drug Delivery Device Product Portfolios and Specifications
13.6.3 H&T Presspart Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 H&T Presspart Main Business Overview
13.6.5 H&T Presspart Latest Developments
13.7 Gerresheimer
13.7.1 Gerresheimer Company Information
13.7.2 Gerresheimer Inhalation Drug Delivery Device Product Portfolios and Specifications
13.7.3 Gerresheimer Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gerresheimer Main Business Overview
13.7.5 Gerresheimer Latest Developments
13.8 Merxin Ltd
13.8.1 Merxin Ltd Company Information
13.8.2 Merxin Ltd Inhalation Drug Delivery Device Product Portfolios and Specifications
13.8.3 Merxin Ltd Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Merxin Ltd Main Business Overview
13.8.5 Merxin Ltd Latest Developments
13.9 3M
13.9.1 3M Company Information
13.9.2 3M Inhalation Drug Delivery Device Product Portfolios and Specifications
13.9.3 3M Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 3M Main Business Overview
13.9.5 3M Latest Developments
13.10 Aerogen Pharma
13.10.1 Aerogen Pharma Company Information
13.10.2 Aerogen Pharma Inhalation Drug Delivery Device Product Portfolios and Specifications
13.10.3 Aerogen Pharma Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Aerogen Pharma Main Business Overview
13.10.5 Aerogen Pharma Latest Developments
13.11 MedPharm
13.11.1 MedPharm Company Information
13.11.2 MedPharm Inhalation Drug Delivery Device Product Portfolios and Specifications
13.11.3 MedPharm Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 MedPharm Main Business Overview
13.11.5 MedPharm Latest Developments
13.12 Kindeva Drug Delivery
13.12.1 Kindeva Drug Delivery Company Information
13.12.2 Kindeva Drug Delivery Inhalation Drug Delivery Device Product Portfolios and Specifications
13.12.3 Kindeva Drug Delivery Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Kindeva Drug Delivery Main Business Overview
13.12.5 Kindeva Drug Delivery Latest Developments
13.13 Boehringer Ingelheim
13.13.1 Boehringer Ingelheim Company Information
13.13.2 Boehringer Ingelheim Inhalation Drug Delivery Device Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Boehringer Ingelheim Main Business Overview
13.13.5 Boehringer Ingelheim Latest Developments
13.14 Chiesi Farmaceutici SpA
13.14.1 Chiesi Farmaceutici SpA Company Information
13.14.2 Chiesi Farmaceutici SpA Inhalation Drug Delivery Device Product Portfolios and Specifications
13.14.3 Chiesi Farmaceutici SpA Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Chiesi Farmaceutici SpA Main Business Overview
13.14.5 Chiesi Farmaceutici SpA Latest Developments
13.15 Merck & Co, Inc
13.15.1 Merck & Co, Inc Company Information
13.15.2 Merck & Co, Inc Inhalation Drug Delivery Device Product Portfolios and Specifications
13.15.3 Merck & Co, Inc Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Merck & Co, Inc Main Business Overview
13.15.5 Merck & Co, Inc Latest Developments
13.16 Novartis AG
13.16.1 Novartis AG Company Information
13.16.2 Novartis AG Inhalation Drug Delivery Device Product Portfolios and Specifications
13.16.3 Novartis AG Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Novartis AG Main Business Overview
13.16.5 Novartis AG Latest Developments
13.17 PARI international
13.17.1 PARI international Company Information
13.17.2 PARI international Inhalation Drug Delivery Device Product Portfolios and Specifications
13.17.3 PARI international Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 PARI international Main Business Overview
13.17.5 PARI international Latest Developments
13.18 Vectura Group Plc
13.18.1 Vectura Group Plc Company Information
13.18.2 Vectura Group Plc Inhalation Drug Delivery Device Product Portfolios and Specifications
13.18.3 Vectura Group Plc Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Vectura Group Plc Main Business Overview
13.18.5 Vectura Group Plc Latest Developments
13.19 GlaxoSmithKline
13.19.1 GlaxoSmithKline Company Information
13.19.2 GlaxoSmithKline Inhalation Drug Delivery Device Product Portfolios and Specifications
13.19.3 GlaxoSmithKline Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 GlaxoSmithKline Main Business Overview
13.19.5 GlaxoSmithKline Latest Developments
13.20 Koninklijke Philips NV
13.20.1 Koninklijke Philips NV Company Information
13.20.2 Koninklijke Philips NV Inhalation Drug Delivery Device Product Portfolios and Specifications
13.20.3 Koninklijke Philips NV Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Koninklijke Philips NV Main Business Overview
13.20.5 Koninklijke Philips NV Latest Developments
13.21 OMRON Corporation
13.21.1 OMRON Corporation Company Information
13.21.2 OMRON Corporation Inhalation Drug Delivery Device Product Portfolios and Specifications
13.21.3 OMRON Corporation Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 OMRON Corporation Main Business Overview
13.21.5 OMRON Corporation Latest Developments
13.22 Sunovion Pharmaceuticals, Inc
13.22.1 Sunovion Pharmaceuticals, Inc Company Information
13.22.2 Sunovion Pharmaceuticals, Inc Inhalation Drug Delivery Device Product Portfolios and Specifications
13.22.3 Sunovion Pharmaceuticals, Inc Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Sunovion Pharmaceuticals, Inc Main Business Overview
13.22.5 Sunovion Pharmaceuticals, Inc Latest Developments
13.23 Teva Pharmaceutical Industries Ltd
13.23.1 Teva Pharmaceutical Industries Ltd Company Information
13.23.2 Teva Pharmaceutical Industries Ltd Inhalation Drug Delivery Device Product Portfolios and Specifications
13.23.3 Teva Pharmaceutical Industries Ltd Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.23.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.24 Yisuo Intelligent
13.24.1 Yisuo Intelligent Company Information
13.24.2 Yisuo Intelligent Inhalation Drug Delivery Device Product Portfolios and Specifications
13.24.3 Yisuo Intelligent Inhalation Drug Delivery Device Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Yisuo Intelligent Main Business Overview
13.24.5 Yisuo Intelligent Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
